Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin.

@article{Schiffelers2003AntitumorEO,
  title={Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin.},
  author={R. Schiffelers and G. Koning and T. L. T. ten Hagen and M. Fens and A. J. Schraa and A. P. C. A. Janssen and R. J. Kok and G. Molema and G. Storm},
  journal={Journal of controlled release : official journal of the Controlled Release Society},
  year={2003},
  volume={91 1-2},
  pages={
          115-22
        }
}
  • R. Schiffelers, G. Koning, +6 authors G. Storm
  • Published 2003
  • Chemistry, Medicine
  • Journal of controlled release : official journal of the Controlled Release Society
  • Angiogenesis is a key process in the growth and metastasis of a tumor. Disrupting this process is considered a promising treatment strategy. Therefore, a drug delivery system specifically aiming at angiogenic tumor endothelial cells was developed. Alpha v beta 3-integrins are overexpressed on actively proliferating endothelium and represent a possible target. For this, RGD-peptides with affinity for this integrin were coupled to the distal end of poly(ethylene glycol)-coated long-circulating… CONTINUE READING
    292 Citations
    Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome.
    • 109
    Improved drug delivery and therapeutic efficacy of PEgylated liposomal doxorubicin by targeting anti-HER2 peptide in murine breast tumor model.
    • 27
    Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis
    • 377
    • PDF
    PEGylated liposomal doxorubicin targeted to α5β1-expressing MDA-MB-231 breast cancer cells.
    • K. Shroff, E. Kokkoli
    • Chemistry, Medicine
    • Langmuir : the ACS journal of surfaces and colloids
    • 2012
    • 60

    References

    SHOWING 1-10 OF 20 REFERENCES
    Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.
    • 5,002
    • PDF
    Mechanisms and future directions for angiogenesis-based cancer therapies.
    • F. Scappaticci
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 2002
    • 240
    Mechanistic insights on the inhibition of tumor angiogenesis
    • B. Jimenez
    • Biology, Medicine
    • Journal of Molecular Medicine
    • 2001
    • 65
    • PDF
    Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.
    • 1,440
    • PDF
    Sterically stabilized liposomes labeled with indium-111 to image focal infection.
    • 110
    • PDF